LC-MS/MS of large molecules in a regulated bioanalytical environment - Which acceptance criteria to apply?

Bioanalysis

Volumn 5, Issue 18, 2013, Pages 2211-2214

  Knutsson, Magnus ^a   Schmidt, Ronald ^b   Timmerman, Philip ^c  

^a Ferring Pharmaceuticals AS   (Denmark)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^c Bioanalysis Janssen Research and Development   (Belgium)

Author keywords

acceptance criteria; European Bioanalysis Forum; LC MS; peptide; protein; regulated bioanalysis

Indexed keywords

LIGAND; OLIGONUCLEOTIDE; PEPTIDE; PROTEIN;

ANALYSIS; ANALYTIC METHOD; BINDING AFFINITY; BIOANALYSIS; LIGAND BINDING ASSAY; LIQUID CHROMATOGRAPHY; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; MOLECULAR DYNAMICS; MOLECULAR IMAGING; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; PROTEIN DETERMINATION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; METABOLISM;

CHROMATOGRAPHY, LIQUID; OLIGONUCLEOTIDES; PEPTIDES; PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84885004683     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.193     Document Type: Review

References (20)

1. Liu G. Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validation. J. Chromatogr. A 1(284), 155-162 (2013).
2. Ewles M, Goodwin L. Bioanalytical approaches to analyzing peptides and proteins by LC-MS/MS. Bioanalysis 3(12), 1379-1397 (2011).
3. van den Broek I, Niessen WM, van Dongen WD. Bioanalytical LC-MS/MS of protein-based biopharmaceuticals. J. Chromatogr. B 929, 161-179 (2013).
4. Timmerman P, Lausecker B, Barosso B et al. 'Large Meets Small': connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS). Bioanalysis 4(6), 627-631 (2012).
5. Wilson SF, Li H, Rose MJ et al. Development and validation of a method for the determination of a therapeutic peptide with affinity for the human B1 receptor in human plasma using HPLC-MS/MS. J. Chromatogr. B 878, 749-757 (2010).
6. Kim M K, Lee T H, Suh J H et al. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma. J. Chromatogr. B 878, 2235-2242 (2010).
7. Lövgren U, Johansson S, Jensen LS et al. Quantitative determination of peptide drug in human plasma samples at low pg/ml levels using coupled column liquid chromatography-tandem mass spectrometry. J. Pharma. Biomed. Anal. 53, 537-545 (2010).
8. Hage DS, Anguizola JA, Bi C et al. Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments. J. Pharm. Biomed. Anal. 69, 93-105 (2012).
9. Thomas A, Schänzer W, Delahaut P, Thevis M. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. Methods 56(2), 230-235 (2012).
10. Becker J, Hoofnagle A, Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS. Bioanalysis 4(3), 281-290 (2012).
11. Li F, Fast D, Michael S. Absolute quantitation of protein therapeutics in biological matrices by enzymatic digestion and LC-MS. Bioanalysis 3(21), 2459-2480 (2011).
12. Heudi O, Barteau S, Zimmer D et al. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. Anal. Chem. 80(11), 4200-4207 (2008).
13. van den Broek I, Sparidans RW, Schellens JHM, Beijnen JH. Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices: measurements of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma. J. Chromatogr. B 854, 245-259 (2007).
14. Neubert H. Muirhead D, Kabir M et al. Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor. Anal. Chem. 85(3), 1719-1726 (2013).
15. Guan F, Uboh CE, Soma LR et al. LC-MS/MS method for confirmation of recombinant human erythropoietin and darbepoetin α in equine plasma. Anal. Chem. 79, 4627-4635 (2007).
16. Gil J, Cabrales A, Reyes O et al. Development and validation of a bioanalytical LC-MS method for the quantification of GHRP-6 in human plasma. J. Pharm. Biomed. Anal. 60, 19-25 (2012).
17. US FDA. Guidance for Industry: Bioanalytical Method Validation. US FDA, Rockville, MD, USA (2001).
18. European Medicines Agency. Guideline on Bioanalytical Method Validation (2011).
19. Timmerman P, Herling C, Stoellner D et al. European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development. Bioanalysis 4(15), 1883-1894 (2012).
20. European Bioanalysis Forum 5th Open Symposium. Old Battles, New Horizons. http://bcn2012.europeanbioanalysisforum.eu